M$A STARTING TO HAPPEN IN US COMPANIES BUYING UP SMALL AI PATEND COMPANIES IN TRENCHED IN BIG CITY CANADA. AI drug developer Recursion Pharmaceuticals has brought two more AI-focused companies with their own discovery platforms under its wing in an acquisition worth $87.5 million, the company announced today.
Recursion is buying both companies, Cyclica and Valence, mostly in equity. The deals come as insiders predict a surge in biotech M&A — with smaller players, not just Big Pharma, ready to jump on tuck-in acquisitions of even smaller companies.WHAT SAY YOU ON THESE DEVELOPMENTS HAPPENING IN THE SLOW MONTHS OF SUMMER.